This tragedy once again points to the need for better heart and cardiovascular screening and awareness of congenital heart defects in our young athletes.
– David Dansereau,MSPT know-stroke.org
As reported in the March 2013 Journal of Invasive Cardiology (J INVASIVE CARDIOL 2013;25(3):162-164)
Abstract: A 34-year-old male patient was referred for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction with cardiogenic shock and was found to have embolic left coronary artery occlusion and subsegmental pulmonary artery emboli as a consequence of venous thrombosis to trauma to the thigh in the presence of a patent foramen ovale.
“The case should cause reconsideration of the current Food and Drug Administration restriction regarding indication for PFO closure to patients with a recurrent event despite medical treatment.”